9 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... #Management #Pulmonary ... #LABA #ICS #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... corticosteroid; LABA ... #Algorithm #Management ... #Pulmonary #LABA ... #ICS #Pharmacology
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Medications, Spinal Cord Injury ... • Obstructive: Pulmonary ... Abdominal compartment syndrome ... #criticalcare #algorithm ... #treatment #management
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
Syndromes - OnePager ... WORKUP & DIAGNOSIS Labs ... quantify renal injury ... differential #diagnosis #management ... #treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome ... Triggers: ATRA treatment ... Diagnosis: • Labs ... Imaging: CXR- pulmonary ... APML #diagnosis #management
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Marrow (Toxic injury ... aplastic anemia) Labs ... aplastic anemia Treatment ... Anemia #oncology #hematology ... #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... acute coronary syndrome ... #differential #algorithm ... #management #cardiology
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
cytotoxic lung injury ... starting amiodarone treatment ... respiratory distress syndrome ... Labs: • Nonspecific ... #diagnosis #management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management